← ANALYSTS · TIPRANKS

Martin Fan · Wedbush

#177among 12,504 TipRanks analysts★★★★★★★★★★
Hits 87% 34 of 39 ratings made money (TipRanks, all the analyst’s ratings)
Average return of a rating +94.8% Over a year after the rating, TipRanks’ measure
Our companies rated now 10 Buy / hold / sell: 8 / 2 / 0
Upside of the analyst’s targets +283.8% Average over 10 current targets, to the last price
The market’s answer to the ratings −2.7% Day-0 move against SPY in the rating’s direction, average over 3 upgrades, downgrades and target changes
Date · added, NYStockAction RatingPrice target Upside Move vs SPY
Oct 13on TipRanks 09:25 TRAXIWMFirst Tracks Biotherapeutics Inc · $1.3B Reiterated Buy $70.00 +103.1% −6.9%next day +8.8%
Sep 24on TipRanks 08:25 ORKAIWMOruka Therapeutics · $4.9B Reiterated Buy $165 +129.4% −4.8%next day −1.7% · 5 days −2.0%
Sep 23on TipRanks 08:12 NKTRIWMNektar Therapeutics · $1.3B Reiterated Hold $80.00 → $50.00−37.5% +39.7% −4.7%next day +3.1% · 5 days +5.7%
Sep 10on TipRanks Oct 1 10:25 IMUXImmunic · $104M Reiterated Buy $45.00 +545.6% −2.3%next day −4.4% · 5 days −13.2%
Aug 18on TipRanks 08:45 RNACIWMCartesian Therapeutics · $199M Reiterated Buy $38.00 +506.1% +0.9%next day +13.8% · 5 days +13.0%
Aug 12on TipRanks 09:56 ZURAIWMZura Bio · $423M Reiterated Buy $22.00 +467.0% +3.7%next day −3.3% · 5 days +1.5%
Aug 12on TipRanks 09:56 VORIWMVor Biopharma · $1.1B Reiterated Hold $18.00 → $27.00+50.0% +49.8% −5.5%next day +3.6% · 5 days +6.0%
Aug 11on TipRanks 08:12 SANAIWMSana Biotechnology · $698M Reiterated Buy $7.00 +208.4% +5.3%next day −0.8% · 5 days −3.8%
May 21on TipRanks 09:35 ARTVIWMArtiva Biotherapeutics, Inc. · $289M Reiterated Buy $40.00 +583.8% +1.7%next day −1.9% · 5 days −2.6%
May 8on TipRanks 13:05 ACRSIWMAclaris Therapeutics · $514M Reiterated Buy $10.00 +204.9% +0.6%next day +0.2% · 5 days −8.5%

Ratings of the stocks the collector reads (the companies of QQQ, SPY, IWM, SMH, SOXL and SOXS and the other US stocks of TipRanks’ feed of new ratings) that it has kept: every new one since 30 September 2026, before that the analyst’s latest rating of each company. Upside is the target over the stock’s last price. The analyst at TipRanks ↗